Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Another Black Eye For Valeant, But Salix Is The Culprit

Executive Summary

Long before Valeant Pharmaceuticals International Inc. acquired North Carolina-based Salix Pharmaceuticals Ltd. in 2015, the latter firm was engaging in illegal kickback activities, for which its parent company is now left holding the bag in paying out $54m to settle the charges – another black eye for the Canadian firm's reputation.


Related Content

Big Pharma's Bad Attitude: Are CEOs Giving Industry A Bad Rep?
Ackman Warned Valeant 'Rome Was Burning,' Begged 'Tell The Truth'
Regrets For Valeant's Ackman, Pearson; Big Pay For Papa
Valeant: Another Fine Mess
'Fraud' Accusations Vex Valeant, Slam 'Specialty' Shares
Valeant Latest Congressional Target Over High Drug Prices


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts